tiny-TIMsg

The SurroGUT™ platform is a powerful tool for developing advanced predictive Physiologically Based Biopharmaceutics (PBB) models and mechanistic in vitro–in vivo correlations (IVIVCs). It uniquely combines TIM dissolution experiments, TIM gastrointestinal fluids, cell-based microfluidics, and GastroPlus® s...

The TIM-2, as part of the SurroGUT™ platform, is the dynamic in vitro model of the large intestine. The lower GI model, with its anaerobic compartment containing highly metabolic active intestinal microbiota, precisely mimics the physiological conditions of the colon in vivo. TIM-2 can simulate the pr...

InnoGI Technologies (formerly The TIM Company) is pleased to announce an exciting, market-driven collaboration with Simulations Plus to combine its TIM Technology, part of the InnoGI SurroGUT™ platform, with the GastroPlus® and ADMET Predictor® modelling software offered by Simulations Plus.

Discover how the SurroGUT™ platform, mimicking with high fidelity the human GI tract, offers valuable visibility and insights into both pharmaceutical drug development and food research projects. Whether you're looking to accelerate your pharmaceutical pipeline or innovate within the food industry, SurroGUT™ equips you with the tools to significantly reduce risks and achieve a faster time to market.